Cannabis use in liver transplant candidates and recipients
- PMID: 38289264
- DOI: 10.1097/LVT.0000000000000335
Cannabis use in liver transplant candidates and recipients
Abstract
The increasing legality and acceptance of cannabis sale and consumption across the United States has led to a measurable increase in cannabis use nationwide, including in liver transplant (LT) candidates and recipients. With over 75% of liver transplant recipients transplanted in states with legalized use of medicinal and/or recreational cannabis, liver transplant clinicians must have expertise in the assessment of cannabis use given its potential impact on clinical care. In this review, the authors provide an understanding of nomenclature and tools to assess cannabis use, highlight essential components to guide clinical policy development and implementation, and discuss the potential impacts of cannabis use on patients' transplant course.
Copyright © 2024 American Association for the Study of Liver Diseases.
References
-
- Yan K, Forman L. Cannabinoid use among liver transplant recipients. Liver Transpl. 2021;27:1623–32.
-
- Page RL II, Allen LA, Kloner RA, Carriker CR, Martel C, Morris AA, et al. Medical marijuana, recreational cannabis, and cardiovascular health: A scientific statement from the American Heart Association. Circulation. 2020;142:e131–e52.
-
- National Conference of State Legislatures. June 22, 2023. Accessed July 20, 2023. https://www.ncsl.org/health/state-medical-cannabis-laws
-
- Marijuana Policy Project. Medical cannabis laws and anti-discrimination provisions. February 2022. Accessed August 24, 2023. https://www.mpp.org/issues/medical-marijuana/medical-marijuana-laws-anti...
-
- Official Publication of the State of Minnesota, Revisor of Statutes. 152.32 Protections For Registry Program Participation. 2023. Accessed August 24, 2023. https://www.revisor.mn.gov/statutes/cite/152.32
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
